Mac-Chem Products (India) Pvt.Ltd DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Virtual Booth

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

DIGITAL CONTENT

INTERVIEW #SpeakPharma, VLOG #PharmaReel, DATA COMPILATION #PharmaFlow, 2 NEWS #PharmaBuzz

media
INTERVIEW #SpeakPharma
VLOG #PharmaReel
DATA COMPILATION #PharmaFlow
2 NEWS #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

91 All APIs, 14 USDMF, 14 CEP/COS, 32 EU WC, 8 KDMF, 91 Listed APIs

91 All APIs
14 USDMF
14 CEP/COS
32 EU WC
8 KDMF
91 Listed APIs

SERVICES

API Manufacturing

pharmaServices
API Manufacturing

INSPECTIONS & REGISTRATIONS

1 FDA, 1 EDQM, 1 WHO-GMP

inspections
1 FDA
1 EDQM
1 WHO-GMP

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Established in 2010, Mac-Chem is a NMM Group company. Mac-Chem is focused on oncology and other niche specialty APIs. It supplies quality APIs to the top 15 oncology players in India. It is also the sole manufacturer of some of the molecules in the oncology segment and general segment. The company’s investments are mostly geared toward exports, especially to regulated markets. Mac-Chem has a cGMP-compliant manufacturing facility near Mumbai in India. The company’s facility is USFDA, EDQM, COFEPRIS, ANVISA, MFDS-Korea, WHO-GMP-approved and ISO-certified. Mac-Chem enjoys a global reach, serving more than 40 countries.

DCAT WeekDCAT Week

Not Confirmed

Not Confirmed

17-20 March, 2025

New York, USA
Antibody EngineeringAntibody Engineering

Not Confirmed

Not Confirmed

15-19 December, 2024

Marriott Marquis San Diego
Pharma, Lab & Chemical...Pharma, Lab & Chemical Expo

Not Confirmed

Not Confirmed

03-05 January, 2025

Chennai, India

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown

Country

India

Address

304, Town Centre, 3rd Floor, Andheri (East), Mumbai 400059

Telephone

91 22 4093 9000

enquiries@pharmacompass.com

Website

https://www.macchemgroup.com/

https://in.linkedin.com/company/mac-chem-product-india-pvt-ltd

YouTube

Digital content

Create Content with PharmaCompass, ask us

INTERVIEW #SpeakPharma

[Sponsored by another company]

“Translational Pharmaceutics, our flagship platform for drug development, empowers our clients with unparalleled flexibility”

This week, SpeakPharma interviews Denise Sutton, Chief Operating Officer and Site Head at Quotient Sciences’ Nottingham facility in the UK. Quotient Sciences is a drug development and manufacturing accelerator that offers the innovative Translational Pharmaceutics platform to support customers in overcoming drug development challenges. Sutton has been with the company for over 25 years. In this interview, she provides insights into the evolution of Quotient Sciences’ Nottingham facility and discusses how the organization has transformed from a small 10-bed clinic to a comprehensive drug development campus with six GMP suites. She also shares her perspective on the company’s unique approach to integrating drug development services. HIGHLIGHTS// evolution of Quotient Sciences’ Nottingham facility/ unique approach to integrating drug development services How has the Nottingham site transformed from when it was founded, to what it is today? Initially, we were a small company with fewer than 50 employees, a 10-bed clinic, and a single lab. Over 90 percent of our work focused on gamma scintigraphic imaging (a diagnostic test that creates images of the body’s internal organs and tissues using gamma rays). Due to the short half-life radionuclides we used to label dosage forms, every product we manufactured had a limited time to be dosed. At the end of 1999, we moved our headquarters to a purpose-built, two-storey facility—now known as Trent House on our now much larger Nottingham campus. We built three good manufacturing practice (GMP) suites on the top floor and three clinical wards on the bottom floor. These were very early days that marked the start of our Translational Pharmaceutics platform. We continued to expand the range of scintigraphy applications we offered in response to changing customer requirements until, in 2008, when we approached the MHRA (UK’s Medicines and Healthcare products Regulatory Agency) with a new request. We asked if it might be possible to work at the same pace as we did in our scintigraphic imaging studies, but do so for conventional drug development, without the radiolabel. We explored the application of ICH Q8 Quality by Design (QbD) guidelines to introduce a compositional design space into the CMC section of our regulatory dossier. This officially created a methodology for applying the Translational Pharmaceutics platform, and we haven't looked back since. Today, we have expanded substantially. Our Nottingham site is a campus of five buildings. We have development and analytical labs, six GMP suites, six clinical wards with a total of 85 beds (where we conduct healthy volunteer phase 1 clinical studies), and many talented colleagues covering our spectrum of CRO and CDMO services. HIGHLIGHTS// officially created a methodology for applying the Translational Pharmaceutics platform/ development and analytical labs/ six GMP suites How is Translational Pharmaceutics applied to drug development programs? We apply Translational Pharmaceutics across three core applications: first-in-human clinical studies, drug product optimization programs through rapid formulation development and clinical testing, and as a part of human ADME (absorption, distribution, metabolism, and excretion) programs. No matter how a client chooses to work with us to apply Translational Pharmaceutics, the benefits of using a single organization and project management team to integrate services lets our clients remain in control and one step ahead of the emerging data that impacts the success of their molecule. Over all these years, our flagship Translational Pharmaceutics platform for drug development has remained unchanged in the way it empowers our customers and offers them unparalleled flexibility. HIGHLIGHTS// three core applications/ benefits of using a single organization/ clients remain in control What would you say are the key strengths of Quotient Sciences’ Nottingham site? How do you support customer programs? Nowhere else would a single project manager oversee such a broad spectrum of activities, let alone be expected to ensure seamless, timely progression across functions that in any other company (i.e. at other CDMOs or CROs) would be delivered through multiple operating areas or through the use of a combination of third-party vendors. The project managers do face challenges. But by working with the project team, they are able to anticipate, avoid, and mitigate any impact whenever necessary. We know that time is incredibly valuable for our customers. A project Gantt chart is our project management team’s guiding light. I believe our project management team is truly world-leading – they communicate well, show great compassion, and lead with integrity. I’m super proud of our high-performing, supportive, cross-functional teams that support our customers when they trust their molecules to us, and work collaboratively to deliver the best possible service. After 25 years at Quotient, I continue to really enjoy going to work. I am indebted to various colleagues for helping me continue to feel this way. HIGHLIGHTS// project management team is truly world-leading/ high-performing, supportive, cross-functional teams/ 25 years at Quotient

Impressions: 4587

VLOG #PharmaReel

[Sponsored by another company]

Full-Service Generic API Company

DATA COMPILATION #PharmaFlow

[Sponsored by another company]

CDMO Activity Tracker: Bora, PolPharma make acquisitions; Evonik, EUROAPI, Porton announce technological expansions

The contract development and manufacturing organization (CDMO) space continued to grow at an impressive pace in the second half (H2) of 2024, with significant progress being made across cell and gene therapies (CGTs), antibody-drug conjugates (ADCs), novel drug modalities, and digital solutions.Some of the key players in the CDMO space include Lonza, EUROAPI, Evonik, SEQENS, Fujifilm Diosynth Biotechnologies, Quotient Sciences, Axplora, PolPharma, and Famar from Europe; Mission CDMO, LGM Pharma, Veranova, and Thermo Fisher from the US; and Samsung Biologics, Bora Pharmaceuticals, and Porton Pharma Solutions from Asia. Texas-based Mission CDMO has been in the pharma industry for over 75 years. Today, it is known for its comprehensive contract services and high-quality manufacturing capabilities that have reinforced its position as a trusted partner. View CDMO Activity Tracker for H2 2024 (Free Excel Available)Bora, PolPharma drive CDMO acquisitions; Samsung Biologics clocks over US$ 4 bn in contract valueThe second half of 2024 saw several high-value acquisitions and expansions that reshaped the CDMO landscape. South Korea-based Samsung Biologics clocked a cumulative contract value of over US$ 4 billion. It signed its largest manufacturing deal with an Asia-based pharmaceutical company, valued at US$ 1.24 billion. It also announced a series of manufacturing deals with a European drugmaker worth over US$ 668 million. Samsung Biologics is also building a dedicated ADC facility that is likely to be complete soon. Taiwan’s largest CDMO, Bora Pharmaceuticals, announced its second acquisition of the year. It bought New Jersey-based Pyros Pharmaceuticals, a developer of rare disease treatments. Pyros recently launched Vigafyde, the only ready-to-use vigabatrin oral solution and the first new product approved to treat infantile spasms in 15 years. Bora also announced a strategic investment in Tanvex Biopharma, thereby creating a global platform for biologics development and supply.PolPharma acquired Ziołolek, a renowned manufacturer of dermatological products, medical devices, and OTC medicines, thereby expanding its product portfolio. It also launched a state-of-the-art HPAPI (highly potent active pharmaceutical ingredients) facility in Poland, which is being seen as another step towards securing Europe’s drug supply chain.In other developments, Avid Bioservices got acquired by funds managed by Ampersand and British healthcare investment firm GHO Capital Partners in an all-cash deal worth US$ 1.1 billion. And Agilent Technologies agreed to acquire Canadian specialty CDMO Biovectra for US$ 925 million, thereby enhancing its capabilities in gene-editing technologies and sterile fill-finish services. View CDMO Activity Tracker for H2 2024 (Free Excel Available) Evonik, EUROAPI, Porton Pharma, GSK announce tieups, technological expansionsSeveral CDMOs announced new collaborations and acquired new capabilities to enhance their service offerings. Evonik expanded its formulation capabilities for lipid nanoparticles used for mRNA and gene therapies through a collaboration with KNAUER Wissenschaftliche Geräte. This partnership aims to expand Evonik’s portfolio of biosolutions.Evonik is also restructuring its keto and pharma amino acid business to focus on strategic core growth areas. Evonik launched Eudracap colon functional capsules for targeted delivery of oral drugs. These ready-to-fill capsules are designed to release their contents specifically in the colon, improving the efficacy of treatments for various gastrointestinal conditions. Evonik also opened a new facility for drying aqueous dispersions of Eudragit polymers in Darmstadt, Germany. This facility will enhance Evonik’s capabilities in producing high-quality polymers for pharmaceutical applications.EUROAPI launched a new AI-powered Electronic Batch Record solution in collaboration with Aizon to enhance manufacturing productivity. This collaboration aims to digitize operations towards more data-driven manufacturing, focusing on small-scale productions and highly flexible plants.Porton Pharma Solutions has expanded its reach through several strategic initiatives. In October, Porton entered into a partnership with Shanghai InnoStar to enhance its service offerings beyond small molecules, targeting peptides, oligonucleotide drugs, conjugated drugs, and advanced therapies. It continued to grow its capabilities by enhancing its GMP manufacturing capacity in Fengxian, Shanghai (China). The facility’s expansion is aimed at increasing the production of novel therapies, including peptides and oligonucleotide drugs. These moves are part of Porton’s broader strategy to position itself at the forefront of advanced pharmaceutical manufacturing.Corden Pharma is investing € 900 million (US$ 985 million) over the next three years to expand its peptide platform facilities in Colorado (US) and Europe. While the US site will help meet the rising demand for GLP-1 peptides, in Europe, CordenPharma will construct a greenfield facility for small to large-scale peptide development and manufacturing.CDMO Touchlight signed a licensing agreement with GSK that grants the drug behemoth non-exclusive rights to use Touchlight’s proprietary enzymatic doggybone DNA (dbDNA) technology for the development and production of mRNA-based products, particularly vaccines. Curia also integrated enzymatic dbDNA solutions through a collaboration with Touchlight, enhancing mRNA production for vaccine and cancer therapies. View CDMO Activity Tracker for H2 2024 (Free Excel Available) Lonza, Merck, Dr. Reddy’s owned Aurigene invest in cell and gene therapiesThe CGT space continued to draw both deals and investments. Lonza and Vertex signed a long-term commercial supply agreement for Casgevy, the world’s first CRISPR/Cas9 gene-edited cell therapy, to treat sickle cell disease and beta thalassemia. This agreement includes manufacturing at Lonza’s Geleen (the Netherlands) cell therapy manufacturing facility, with plans to expand to Portsmouth, New Hampshire (US).Miltenyi Biotec began manufacturing lentiviral vectors for Adaptimmune’s Tecelra, the first engineered TCR T-cell therapy for the rare soft tissue cancer synovial sarcoma approved by the US Food and Drug Administration.Merck KGaA commenced commercial production at its first GMP-compliant manufacturing line for cell culture media (CCM) in China. This facility addresses the growing local demand for quality custom CCM used in biopharmaceuticals, vaccines, and novel therapeutics.Aurigene and Edity Therapeutics announced a strategic collaboration in cell therapy, with Aurigene providing cell therapy discovery services to support Edity’s clinical development. Additionally, Aurigene and its parent, Dr. Reddy’s Laboratories, signed a memorandum of understanding (MoU) with Kainomyx for the development and commercialization of an affordable anti-malarial drug. ProBio and UCI Therapeutics signed an MoU for a comprehensive collaboration in gene delivery technologies, including viral and non-viral approaches. Additionally, Korea’s VaxCell-Bio partnered with ProBio to accelerate the development of its chimeric antigen receptor (CAR)-related therapies.The ADC market continued to be a hotbed of innovation and strategic expansion. Merck KGaA invested € 70 million (US$ 75 million) to triple its ADC manufacturing capacity at its Missouri (US) facility, aiming to support the rising demand for oncology therapies.Sterling Pharma entered into a partnership with GlycoNex to support the clinical trials of their ADCs that target solid tumors. And, NJ Bio and Charles River Laboratories also announced a collaboration to optimize ADC manufacturing.The adeno-associated viral (AAV) vector field also saw activity with Rentschler Biopharma and Forge Biologics announcing the launch of a new service offering and a manufacturing platform, respectively. Similarly, Andelyn Biosciences was selected by Hubble Therapeutics to manufacture clinical grade AAV.Meanwhile, Lonza has gone in for a restructuring exercise in order to become a “pure-play CDMO”. It has exited its capsules and health ingredients business, and adopted a new organizational structure. The Swiss CDMO has also extended a collaboration with a major global biopharmaceutical partner for commercial-scale manufacture of ADCs. View CDMO Activity Tracker for H2 2024 (Free Excel Available) Our viewAs pharmaceutical development becomes increasingly complex, CDMOs are no longer just manufacturing partners, but critical innovation hubs. Little wonder then that 2024’s biggest pharma deal was in the CDMO space – Novo Holdings’ US$ 16.5 billion buyout of Catalent. This trend should gather momentum. We expect more M&A activity in this space in 2025.

Impressions: 400

NEWS #PharmaBuzz

Mac-Chem Products’ Boisar facility successfully renews EU-GMP certification

18 Apr 2024

// PHARMABIZ

Mac-Chem Products Fails EDQM Inspection

16 Nov 2022

// EDQM

ALL APIs

Click the button for full data set

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

CEP/COS

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

Only 10 entries up to this point, click to access all

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

LISTED APIs

Only 10 entries up to this point, click to access all

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Services

Upload your portfolio for free, ask us

API Manufacturing

Click here to discover the service providers for API Manufacturing

Scale Up

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

GMP Manufacturing

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Cytotoxic Compound

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Injectable / Sterile APIs

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

High Potency APIs (HPAPIs)

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Inspections and registrations

Upload your audits for free, ask us

FDA

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EDQM

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

WHO-GMP

Only 10 entries up to this point, click to access all

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Contact Mac-Chem Products (India) Pvt.Ltd and get a quotation

Mac-Chem Products (India) Pvt.Ltd is a supplier offers 91 products (APIs, Excipients or Intermediates).

Find a price of Bicalutamide bulk with DMF, CEP offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Cytarabine bulk with DMF, CEP offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Irinotecan Hydrochloride bulk with DMF, CEP offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Ropivacaine Hydrochloride bulk with DMF, CEP offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Succinylcholine Chloride bulk with DMF, CEP offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Capecitabine bulk with DMF offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Carboplatin bulk with DMF offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Dacarbazine bulk with DMF offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Letrozole bulk with DMF offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Anastrozole bulk with DMF offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Neostigmine Methylsulfate bulk with CEP offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Oxaliplatin bulk with DMF offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Pemetrexed Disodium bulk with CEP offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Docetaxel bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Etoposide bulk with CEP offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Gefitinib bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Paclitaxel bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Abiraterone Acetate bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Aciclovir bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Bendamustine Hydrochloride bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Chloramphenicol Sodium Succinate bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Cisplatin bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Colistimethate Sodium bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Erlotinib Hydrochloride bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Esomeprazole Sodium bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Exemestane bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Gemcitabine bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Hydrocortisone Sodium Succinate bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Methotrexate bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Methylprednisolone Sodium Succinate bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Omeprazole Sodium bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Pantoprazole Sodium bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Polymyxin B Sulfate bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Tenoxicam bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Zoledronic Acid bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Afatinib bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Anidulafungin bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Aprepitant bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Axitinib bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Azacitidine bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Bortezomib bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Cabazitaxel bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Carfilzomib bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Choline Chloride bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Cladribine bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Dabigatran Etexilate Mesylate bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Daptomycin bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Dasatinib bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Dexmedetomidine Hydrochloride bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Enzalutamide bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Epinephrine Bitartrate bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Eribulin bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Everolimus bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Fludarabine Phosphate bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Fosaprepitant bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Fosfomycin Sodium bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Glimepiride bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Glutathione bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Hydrocortisone bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Hydrocortisone Acetate bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Ibrutinib bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Idelalisib bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Imatinib Mesylate bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Ketoprofen bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Lapatinib Ditosylate bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Lenalidomide bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Lenvatinib Mesylate bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Methylprednisolone bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Methylprednisolone Hemisuccinate bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Micafungin bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Neostigmine Bromide bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Nilotinib bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Nintedanib Esylate bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Norepinephrine Bitartrate bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Olaparib bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Palbociclib bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Pazopanib Hydrochloride bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Pomalidomide bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Rabeprazole bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Rocuronium Bromide bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Sorafenib bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Sugammadex Sodium bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Sunitinib bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Teicoplanin bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Temozolomide bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Tigecycline bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Topotecan Hydrochloride bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Trabectedin bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Vancomycin Hydrochloride bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Vecuronium Bromide bulk offered by Mac-Chem Products (India) Pvt.Ltd

Find a price of Voriconazole bulk offered by Mac-Chem Products (India) Pvt.Ltd

Company profile for Mac-Chem Products (India) Pvt.Ltd